Does WeGovy or Ozempic work better?long will it take me to lose weight with

In recent times, there has been a lot of buzz surrounding the weight loss results achieved with Ozempic and WeGovy. This has led to some confusion regarding whether WeGovy and Ozempic are the same medication. While both drugs do contain the same active ingredient, semaglutide, there are some differences between them in terms of marketing and dosage. This has led to people wondering which of the two medications work better for weight loss?

Here at Bodyline, we want to help clear up any confusion about the game changing weight loss injections and ensure we are fully informed about the medications and how well they work.

WeGovy or Ozempic’s Active Ingredients?

Both WeGovy and Ozempic’s active ingredient is semaglutide. Semaglutide is classified as a GLP-1 receptor agonist, which means it increases insulin secretion in the stomach lining and lowers glucagon secretion.

In plainer terms, it replicates the effect of the hormone GLP-1 which is naturally released in the intestines following mealtimes. This helps regulate blood sugar levels and can improve glycaemic control for individuals with type 2 diabetes.

But in addition to its positive effects for diabetic individuals, semaglutide assists users in maintaining a caloric deficit by affecting the appetite centre of the brain, suppressing hunger pangs and cravings. This therefore increases the likelihood of successful weight loss. When combined with a supported nutritional plan and an active lifestyle, semaglutide has shown incredible results, with people losing 15% of their body weight on average over a 68-week period.

In terms of active ingredient, both WeGovy and Ozempic work the same way as they are both injectable administrations of semaglutide. Neither WeGovy nor Ozempic work better, as they are the same weight loss medication but in different names due to marketing.

WeGovy or Ozempic’s Target Market?

The differences between WeGovy and Ozempic primarily stem from their respective marketing strategies.

Originally, Ozempic was developed and marketed as a treatment for individuals with type 2 diabetes. However, during studies, it was discovered that Ozempic also had a significant positive impact on weight loss for individuals struggling with obesity.

In light of this, the pharmaceutical manufacturer, Novo Nordisk, decided to rebrand the same medication product as WeGovy, specifically targeting weight loss. Despite these variations in marketing intentions, it is important to note that Ozempic is also safe for use by non-diabetics seeking weight loss.

Those looking for medical weight loss treatments, if safely prescribed, can use WeGovy or Ozempic for the same positive weight loss results, as they work in the same way.  It is the medical weight loss clinician’s decision if and which medical weight loss medication is suitable for you. 

WeGovy or Ozempic’s Dosage

As marketing strategies differ for the medications, one of the main distinctions between WeGovy and Ozempic lies in their dosage and the amount of semaglutide included in the injectable pens.

WeGovy is available in a higher dose than Ozempic, with a maximum dose of 2.4 mg compared to Ozempic’s maximum dose of 1.0 mg.

Depending on your medical history, weight loss goals, and general health, our specialist medical weight loss clinicians at Bodyline will prescribe which weight loss medication is best for you and will guide you through your prescription process to decide which dosage will work best for you and your needs.

In order to be eligible for any weight loss medication including medical weight loss injections like Ozempic or WeGovy, you must have a BMI of over 30 which categorises you as obese and have tried other strategies to lose weight. Additionally, if you overweight with some weight related complications such as type 2 diabetes, you are also able to be prescribed semaglutide.

Find out more about Bodyline’s prescriptive weight loss medications by getting in touch with us today.

WeGovy or Ozempic’s Administration

Both WeGovy and Ozempic are administered once weekly via subcutaneous injection using slimming pens. Think of the pens used by those with a nut allergy, it’s a similar mechanism of prefilled pens to be injected into the body.

These pens provide a controlled dose that lasts throughout the week, effectively suppressing appetite and helping to regulate blood sugar levels. In terms of administration, WeGovy and Ozempic are essentially the same, so neither work better or worse than the other.


Contact Bodyline today to find out more about our safe and effective weight loss programmes and range of treatment options.

"*" indicates required fields

By submitting this form you agree to the Bodyline privacy policy.
This field is for validation purposes and should be left unchanged.

Which Works Better?

The question of which medication works better, WeGovy or Ozempic, ultimately depends on individual factors and preferences. Both medications have proven to be effective in promoting weight loss and managing appetite.

At Bodyline Wellness Clinics, we offer Ozempic and WeGovy as part of a range of medical weight loss drugs and only prescribed as part of our comprehensive medical wellness program.  Bodyline clinicians decide which weight loss medication is suitable to you.  With over 17 years of experience in supporting clients on their weight loss journey, we have witnessed the incredible results achieved with Ozempic and WeGovy. Our program emphasises the importance of ongoing support and dedication, as clinical weight loss is a combination of medication and lifestyle changes.

If you are interested in starting your medical weight loss journey with Bodyline and exploring the benefits of a medical weight loss journey, please contact us today at 0800 995 6036 or fill out our online contact form.

While WeGovy and Ozempic are essentially the same medication in terms of active ingredient and administration, their marketing strategies and dosages differ. The choice between the two medications should be made in consultation with a specialist healthcare professional at Bodyline, who take into account individual needs and ensure safe prescribing.

Related blog posts

Despite the enormous popularity of WeGovy and its incredible impact on weight loss, a shortage of the injectable weight loss therapy has been ongoing in recent months. The semaglutide-containing injection has been dubbed “game-changing” for the treatment of obesity, and demand has been high, but manufacturer Novo Nordisk has struggled to keep up and has only released limited stock.
Mounjaro, also known as tirzepatide, is an innovative prescription medication that has shown great potential in promoting weight loss in clinical trials. Due to rising levels of obesity, and therefore increasing need for treatments, many people are rushing to try game-changing medications like Mounjaro to solve their problems.
In recent years, GLP-1 receptor agonists, also known as GLP-1s, have gained significant attention for their potential in promoting weight loss. These medications, including Ozempic and Saxenda, were originally developed for the treatment of type 2 diabetes but have also shown promising results in helping individuals achieve their weight loss goals.

CONTACT US TODAY

Contact Bodyline to find out more how we can treat and support you to improve your health and wellbeing.

"*" indicates required fields

Select the Bodyline treatment that you would like to discuss*
By submitting this form you agree to the Bodyline privacy policy.